Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NovoCure Ltd Director's Dealing 2015

Oct 1, 2015

31949_dirs_2015-10-01_48062faf-23c6-4b19-878f-d2a4af308df5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2015-10-01

Reporting Person: Palti Yoram (Director, Chief Technology Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 1540927 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Options to Buy Ordinary Shares $0.17 2016-12-25 Ordinary Shares (147825) Direct
Series A Convertible Preferred Shares $ Ordinary Shares (130127) Indirect

Footnotes

F1: Professor Palti shares voting and investment power for the shares held by Bennet Limited.

F2: Fully vested and currently exercisable as of the date hereof.

F3: Pursuant to the issuer's memorandum & articles of association, all outstanding preferred shares of each series will automatically convert into ordinary shares upon consummation of the issuer's initial public offering.

F4: N/A